BRD7389
CAS No. 376382-11-5
BRD7389 ( —— )
产品货号. M26635 CAS No. 376382-11-5
BRD7389 is an inhibitor of RSK family kinase with IC50s of 1.5 μM, 2.4 μM, and 1.2 μM for RSK1, RSK2, and RSK3, respectively.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
规格 | 价格/人民币 | 库存 | 数量 |
5MG | ¥624 | 有现货 |
|
10MG | ¥859 | 有现货 |
|
25MG | ¥1369 | 有现货 |
|
50MG | ¥2001 | 有现货 |
|
100MG | ¥2948 | 有现货 |
|
200MG | 获取报价 | 有现货 |
|
500MG | 获取报价 | 有现货 |
|
1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称BRD7389
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述BRD7389 is an inhibitor of RSK family kinase with IC50s of 1.5 μM, 2.4 μM, and 1.2 μM for RSK1, RSK2, and RSK3, respectively.
-
产品描述BRD7389 is an inhibitor of RSK family kinase with IC50s of 1.5 μM, 2.4 μM, and 1.2 μM for RSK1, RSK2, and RSK3, respectively.(In Vitro):BRD7389 (1 μM) almost completely blocked Carbachol (1 mM)-stimulated cell proliferation, but has little effect on the basal level of proliferation. BRD7389 (0.425, 0.85, 1.7, 3.4, 6.8 μM) induces insulin expression in mouse α-cells and induces a dose-dependent up-regulation of insulin (Ins2) mRNA, peaking at 0.85 μM. BRD7389 increases β-cell-specific gene expression in primary human islet cells. BRD7389 (0.85-6.8μM) significantly up-regulates Pdx1 mRNA expression in mouse α-cell line.
-
同义词——
-
通路Others
-
靶点Other Targets
-
受体——
-
研究领域——
-
适应症——
化学信息
-
CAS Number376382-11-5
-
分子量366.4
-
分子式C24H18N2O2
-
纯度>98% (HPLC)
-
溶解度——
-
SMILESO=C1c2ccccc2-c2c(NCCc3ccccc3)c(=O)[nH]c3cccc1c23
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Christoph Boss,et al. Substituted sulfonylaminopyrimidines. WO2001081338A1
产品手册
关联产品
-
Bromindione
Bromindione is a new anticoagulant.
-
Oxolamine citrate
Oxolamine is a cough suppressant that is available as a generic drug in many jurisdictions.
-
Arundic Acid
Arundic Acid is an astrocyte-modulating agent, delays the expansion of cerebral infarcts by modulating the activation of astrocytes through inhibition of S-100β synthesis.